Septerna (SEPN) Cash & Equivalents (2023 - 2026)

Septerna (SEPN) recorded quarterly Cash & Equivalents of $71.6 million in Q1 2026, down 40.69% quarter-over-quarter from $120.7 million in Q4 2025, and down 65.91% on a YoY basis from $210.0 million in Q1 2025.

Septerna (SEPN) Cash & Equivalents (2023 - 2026) Analysis & Trends

Septerna's Cash & Equivalents history runs 4 years deep, the most recent figure standing at $71.6 million for Q1 2026.

  • In Q1 2026, Cash & Equivalents fell 65.91% year-over-year to $71.6 million; the TTM figure through Mar 2026 stood at $71.6 million (down 65.91% YoY), while the FY2025 annual figure was $120.7 million, down 49.32% from the prior year.
  • Cash & Equivalents was $71.6 million for Q1 2026 at Septerna, down from $120.7 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $320.0 million in Q3 2025 to a low of $71.6 million in Q1 2026.
  • Historically, Cash & Equivalents has averaged $148.9 million across 4 years, with a median of $120.7 million in 2025.
  • The sharpest annual moves came in 2025 and 2026: Cash & Equivalents surged 262.63% in 2025, then tumbled 65.91% in 2026.
  • A 4-year view of Cash & Equivalents shows it stood at $88.5 million in 2023, then jumped by 169.2% to $238.2 million in 2024, then tumbled by 49.32% to $120.7 million in 2025, then slumped by 40.69% to $71.6 million in 2026.
  • The last three Cash & Equivalents figures came in at $71.6 million (Q1 2026), $120.7 million (Q4 2025), and $320.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 32.30 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 1.91 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 286.70 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 18.44 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 2.77 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 7.15 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.49 Bn
9 Abivax 91.96 Bn 91.96 Bn - 558.94 Mn
10 Septerna 1.62 Bn 1.62 Bn - 71.61 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 71.61 Mn
Dec 31, 2025 120.72 Mn
Sep 30, 2025 319.99 Mn
Jun 30, 2025 189.31 Mn
Mar 31, 2025 210.05 Mn
Dec 31, 2024 238.20 Mn
Sep 30, 2024 88.24 Mn
Jun 30, 2024 131.17 Mn
Mar 31, 2024 81.34 Mn
Dec 31, 2023 88.48 Mn
Sep 30, 2023 98.52 Mn